TCH346

TCH346 is a drug in clinical trials to help treat Amyotrophic Lateral Sclerosis (ALS) Though this drug is still in testing it it felt to be a working progress and be a great advancement in health.

External Reference

* [http://www.columbiaals.org/research/d-TCH346-protocol2211.htm Neurological Institute of New York Columbia University]
* [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14572443&dopt=Abstract National Center for Biotechnology Information article]